ChromaDex

Create an alert
to follow the executive moves at ChromaDex.

ChromaDex is one of the...

• Russell 3000.

Most searched biographies at ChromaDex

• Robert Fried, Chief Executive Officer and Director
• Jeffery Baxter, Non-Executive Director
• Steven Block, Non-Executive Director

Click on an executive to view his biography >

Latest M&A news in Pharmaceuticals.

Jazz Pharmaceuticals has announced the acquisition of GW Pharmaceuticals (posted on Feb 4, 2021).
Nordic Capital has announced the acquisition of Advanz Pharma (posted on Feb 1, 2021).
Tilray and Aphria have announced they will merge (posted on Dec 17, 2020).

Other contacts in the Pharmaceuticals industry

• Albert Bourla - Chief Executive Officer and Chairman of the Board at Pfizer
• Per-Olof Attinger - Executive Committee Secretary at Roche
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann

Learn more about the Pharmaceuticals industry >

Latest news about ChromaDex

ChromaDex Corp. - ChromaDex and Watsons Expand TRU NIAGEN® Retail Partnership Through 2021
ChromaDex Corp. - ChromaDex Corp. and Nestlé Health Science Enter Global Commercial License and Supply Agreement for TRU NIAGEN®
ChromaDex Corp. - News
ChromaDex - 2018 Press Releases

ChromaDex on Wikipedia, Google News & Yahoo Finance

ChromaDex on LinkedIn, Twitter & YouTube

ChromaDex has 2,041 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Roche (Switzerland).

Contact by email its executives including Frank Jaksch

Call ChromaDex at +1 949....

View the org chart

Register to receive your alert

Report an error